BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19298528)

  • 21. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
    Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
    Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
    Yan H; Hong Y; Cai Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis.
    Agarwal K; Czaja AJ; Donaldson PT
    Tissue Antigens; 2007 Mar; 69(3):227-35. PubMed ID: 17493146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer.
    Wang LE; Cheng L; Spitz MR; Wei Q
    Lung Cancer; 2003 Oct; 42(1):1-8. PubMed ID: 14512182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD.
    Ben Aleya W; Sfar I; Mouelhi L; Aouadi H; Makhlouf M; Ayed-Jendoubi S; Matri S; Filali A; Najjar T; Ben Abdallah T; Ayed K; Gorgi Y
    World J Gastroenterol; 2009 Aug; 15(29):3643-8. PubMed ID: 19653342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene.
    Feuk L; Prince JA; Breen G; Emahazion T; Carothers A; St Clair D; Brookes AJ
    Hum Genet; 2000 Oct; 107(4):391-6. PubMed ID: 11129341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Lei D; Sturgis EM; Wang LE; Liu Z; Zafereo ME; Wei Q; Li G
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1484-91. PubMed ID: 20501759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
    Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
    Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
    Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
    Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overlapping and Distinct
    Tabatabaei-Panah PS; Moravvej H; Arian S; Fereidonpour I; Behravesh N; Atoon A; Ludwig RJ; Akbarzadeh R
    Immunol Invest; 2020 Feb; 49(1-2):204-214. PubMed ID: 31741398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.
    Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
    Avadanei ER; Giusca SE; Negura L; Caruntu ID
    Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of Association between an XRCC1 Gene Polymorphism and Colorectal Cancer Survival in Thailand.
    Siewchaisakul P; Suwanrungruang K; Poomphakwaen K; Wiangnon S; Promthet S
    Asian Pac J Cancer Prev; 2016; 17(4):2055-60. PubMed ID: 27221895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of IVS14+1 G > A genotype detection in the dihydropyrimidine dehydrogenase gene and pharmacokinetic monitoring of 5-fluorouracil in the individualized adjustment of 5-fluorouracil for patients with local advanced and metastatic colorectal cancer: a preliminary report.
    Cai X; Fang JM; Xue P; Song WF; Hu J; Gu HL; Yang HY; Wang LW
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1247-58. PubMed ID: 24817302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
    Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
    J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
    Wu S; Meng Q; Zhang C; Sun H; Lu R; Gao N; Yang H; Li X; Aschner M; Chen R
    Int J Cancer; 2018 Jul; 143(2):289-297. PubMed ID: 29446085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.